From before birth and onwards there is the potential for obesity. Many of the predisposing factors can be prevented or minimised through educational and preventative strategies that support healthier diet and lifestyles, but the need for active treatment and management of obesity has never been greater. Childhood and adolescence are crucial times for prevention, and treatment in middle age confers important health and quality of life benefits. As obesity becomes more prevalent and the population ages, new and inventive strategies are required to tackle this ubiquitous health problem also in older age groups.
Introduction
Throughout the lifecycle of man -from the prenatal period until old age -there are periods of particular susceptibility to becoming overweight and obese. By recognising when these times are, and how they occur, it should be possible to tailor intervention strategies for the management of the growing problem of obesity and its associated health risks.
At all periods of life, education and prevention are preferable, but in practical terms education and active management are required to correct existing obesity and minimise its ongoing and longer term impact.
Prevention of obesity represents the optimum strategy, and is a constant need as the number of overweight and obese individuals rises. Treatment is also essential, including diet, exercise, behaviour modification and the use of pharmacotherapy as an adjunct in weight loss and longer term weight management.
Although most studies of obesity and most attempts to control its health risks have been aimed at managing obesity in adulthood and middle life, it is increasingly important to consider other periods of risk and look for novel ways to manage obesity from a life-long perspective. Table 1 sets out the different perspectives that we need to consider.
Maternal factors
The first 'high-risk' period in the human life cycle is in utero, where maternal under-nutrition impacts negatively on foetal growth. Although the Barker hypothesis 1 (see Figure 1 ) is sometimes disputed, it is apparent that babies of low birth weight progress into adulthood with a higher risk for hypertension and type 2 diabetes, and their small for gestational age status generally affects normal catch-up growth and has an impact on normal metabolism.
In this case, the 'treatment strategy' of choice should be education and nutrition programmes for expectant mothers and their healthcare support team, with ongoing nutritional advice into childhood. Recent studies continue to show, for example, that breast-feeding is important for infant nutrition and is associated with a lower likelihood of obesity later in life (Table 2) . 2 
Childhood
With an estimated 50% of overweight 5-y-olds likely to become overweight adults and 70% of overweight teenagers likely to remain obese, the developing years have come into sharp focus recently as a vital time for intervention strategies to begin in earnest. Over 600 delegates at the symposium 'The Role of Sibutramine in Weight Management', on which this supplement is based, were asked to identify through an interactive individually based computer system when, in their opinion, was action to control obesity most effective. Well over 60% of the audience identified childhood, and a further 18% selected adolescence as critical periods in which to act to prevent the slide into a cycle of life-long overweight=obesity.
This assessment may reflect the growing recognition that children in many parts of the world are already displaying signs of overweight and obesity in their early school years. Even in the past 10 y the number of children under the age of 5 in the UK who are already overweight has risen sharply ( Table 3) . 3 The first 5 y of life are vitally important in terms of the development of adipose tissue and the subsequent tendencies towards obesity, and 5 y of age is the time from which obesity can be traced for many overweight adolescents. 4 The so-called 'adiposity rebound' phenomenon, occurring after about 5 y, is possibly a very vulnerable period in adipocyte development. The prevalence and severity of obesity in childhood is such that there are now, in several countries, more children under the age of 20 y with type 2 diabetes than with type 1 diabetes -a reversal in the pattern that was seen before the current rise in the numbers of overweight children and young adults. 5 In today's world of fast food, computers and reduced opportunities for physical activity, there is a good and growing case for overweight education and prevention programmes for children. Small-scale intervention programmes have had some success, but for optimum impact, the whole family needs to be involved in the process of re-education.
Adolescence and young adulthood
Adolescence and young adulthood continues to be a time when prevention strategies are crucial and a time when treatment of frank obesity starts to become more of a pressing reality. Once again, recent statistics on the growing problem of obesity in the young show an alarming increase even over a 5 y period in the number of children of 10 -13 y of age who are overweight according to currently accepted growth charts (see Figure 2 ). Figure 1 Barker hypothesis: lifecycle -the proposed causal links. Figure 2 Overweight in German adolescents age 10 -13 y.
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Likewise, a study of Swedish army conscripts (ca 18 y of age) comparing the body mass index (BMI) values in 1995 with that seen in 1971, found a four-fold increase in obesity over this time. 6 Faced with a similar problem in Singapore, the army introduced a strict 5-month programme of weight reduction, refusing to count the training period of conscripts and recruits until they had shed their excess weight. 7 Clearly, by the time young adulthood is reached, the patterns driving obesity are beginning to set and it becomes important to begin intervention to reduce weight while continuing with population preventative strategies.
Prevention or cure?
Prevention alone is notoriously slow and difficult, requiring radical changes in lifestyle in a climate where many people feel overloaded by health and nutritional information, and compliance to lifestyle and dietary change is often poor. There is also a societal feeling and attitude that the requirements for controlling obesity have become so heterogeneous that many of the preventative messages become lost. There is also a realisation that, while this is a large and growing problem, it is a difficult issue for doctors to tackle and therefore one that is often side-lined by apparently more pressing health priorities (Table 4) .
From the age of 20 y, weight generally increases by 3 -4 kg per decade, in part reflecting a reduction of 1% per year in basal metabolic rate. This 'natural' increase in weight is compounded by changing lifestyles that impact negatively on energy balance, for example, marriage, motherhood, sedentary work and lack of regular physical exercise. All communities and national healthy-weight campaigns need to overcome the lack of urgency that prevails about preventing weight gain during the 20s and 30s, particularly in men.
There is good epidemiological evidence to show that between the ages of 18 and 32 y, a rising BMI correlates with an increasing risk of metabolic complications, the best documented of which is type 2 diabetes. 8 With rising obesity comes a greater likelihood of diabetes, hypertension and cardiovascular morbidity and mortality.
Other effects of being overweight that impact on health and quality of life include sleep apnoea, a common but often under-diagnosed and occasionally life-threatening complication of obesity in young and middle-aged men. This problem and others that emerge with obesity and age are important new indications for drug treatment, because weight loss can have remarkable effects on clinical well-being and quality of life. For many patients, it is issues such as those outlined in Table 5 that are important, 9 perhaps because they are more tangible and immediate concerns than obesity-related problems, such as high blood pressure and impaired glucose tolerance.
Middle age and beyond
By middle age, overweight=obesity is likely to be well established, with a significant risk of cardiovascular disease. Although treatment will often focus on the management of comorbid risks, it is imperative that the excess weight of these individuals is tackled through obesity management programmes, some of which will include drug therapy.
For patients and physicians, it is important to communicate the message that even modest weight loss can have a major impact on health and well-being at this stage in life. Even weight loss of just 5% body weight can have marked benefits, particularly in patients with concomitant type 2 diabetes, hypertension or hyperlipidaemias. 10 Weight reduction in these patients is associated with improved glycaemic control, reduced blood pressure, improved lipid profiles and a 20% reduction in premature mortality (Table 6) .
A chronic disease
We need to do more to stress to patients and policy makers that obesity is a chronic disease, requiring years of treatment, while at the same time emphasising the huge benefits of even modest weight reduction.
Parallels can be drawn between obesity and other chronic diseases, where behaviour modification and treatment are important parts of overall management, and where there are guidelines and protocols in place for both everyday management and crisis management of the condition. The nature of chronic diseases is that a cure is seldom expected, instead the goals of management are to gain control over the condition and to limit the associated morbidity and mortality. Treatment strategies offer improved control, but disease often recurs after treatment is withdrawn. In obesity, a life-long approach to management is required, and effective management strategies should be used to suit the stage and progress of the disease.
Little information is available about the benefits of obesity therapy in old people who, if they survive into their 70s, Table 4 Why is prevention so difficult and slow?
Multicausal aetiology of obesity and its associated conditions Different and often long time perspectives for preventive action Low compliance by individuals to health education messages Multiple prevention proposals competing for priority Demand for formalised trial evidence for the effectiveness of preventive measures before action Economic priorities with industrial interests having a higher political priority than health concerns Information overload for consumers Obesity through the ages of man S Rossner are more conscious of the additional mechanical complications of obesity than the metabolic consequences, particularly as hypertension, type 2 diabetes and dyslipidaemias are so common in even the less obese groups at these ages. This demographic group can be hard to define. At age 60 -65 y there may appear to be a higher prevalence of obesity than in more advanced old age, where ill health and dehydration take their toll on numbers as well as on average weight. Nevertheless, visceral obesity in the elderly, as in other age groups, poses significant health threats where a small additional relative risk in practice signifies a substantial extra likelihood of having medical complications of the obesity. With more and more people ageing well into their 80s, a future research priority will be to understand to what extent drug treatment of obesity in old age may be beneficial.
Summary
Prevention of obesity is the optimum strategy and applies to any age group. Treatment is also essential and comprises diet, exercise, behaviour modification and pharmacotherapy. Treatment is appropriate in adolescents and adults; more work needs to be done on appropriate strategies for patients over 65 y of age.
The development of adipose tissue in a child's first 5 y is an important period and has implications for the future development of obesity. There is, therefore, a growing case for prevention strategies aimed at all children, although these strategies are particularly relevant in adolescence when overweight and obesity become a reality for many young adults.
Prevention strategies may have more resonance if they focus on quality of life messages, such as the association of obesity with sexual impairment and joint pain, rather than the improvement of lipid profiles and cardiovascular risk. The chronic nature of obesity means that treatment and prevention strategies must seek to limit morbidity and mortality and must be, necessarily, life long.
